Annual cost of MS drugs in the United States from approval date to 2013

Published by Statista Research Department, Apr 24, 2015
This statistic displays an annual cost comparison of multiple sclerosis (MS) drugs in the United States based on their cost during their approval date and their December 2013 cost. Avonex cost on average 8,723 U.S. dollars per year in 1996 and had increased to a cost of 62,394 U.S. dollars as of December 2013.

Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars)

Drug (U.S. approval date)Approval date annual cost2013 annual cost
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
- - -
Showing entries 1 to 9 (9 entries in total)
Statistic: Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2015

Region

United States

Survey time period

as of December 2013

Supplementary notes

MS: multiple sclerosis
* Interfereon-ß-1b is marketed as Betaseron (Bayer) and Extavia (Novartis).
** Natalizumab was withdrawn from the market in February 2005 to evaluate progressive multifocal leukoencephalopathy risk and was reintroduced in June 2006.

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Drug prices in the U.S. "

Other statistics that may interest you Drug prices in the U.S.

Market overview

7

United States vs. abroad

7

Price increase

7

Biosimilars' effects

5

Consumers' views

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.